1834 Investment Advisors Co. trimmed its position in shares of Oracle Co. (NYSE:ORCL – Free Report) by 17.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,075 shares of the enterprise software provider’s stock after selling 1,730 shares during the quarter. 1834 Investment Advisors Co.’s holdings in Oracle were worth $1,376,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of the company. Fairway Wealth LLC purchased a new stake in shares of Oracle during the second quarter worth $27,000. POM Investment Strategies LLC acquired a new stake in Oracle in the 2nd quarter valued at about $30,000. Bbjs Financial Advisors LLC purchased a new position in shares of Oracle in the 2nd quarter valued at about $35,000. Reston Wealth Management LLC acquired a new position in shares of Oracle during the third quarter worth about $44,000. Finally, Quest Partners LLC purchased a new stake in shares of Oracle during the second quarter worth approximately $40,000. 42.44% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In other Oracle news, EVP Maria Smith sold 6,320 shares of the firm’s stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $165.00, for a total value of $1,042,800.00. Following the sale, the executive vice president now directly owns 42,889 shares of the company’s stock, valued at approximately $7,076,685. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 42.20% of the company’s stock.
Analysts Set New Price Targets
Get Our Latest Stock Report on ORCL
Oracle Trading Up 1.3 %
Shares of Oracle stock opened at $171.82 on Wednesday. The business has a 50 day moving average price of $164.71 and a 200 day moving average price of $143.02. The company has a market capitalization of $476.12 billion, a P/E ratio of 44.28, a P/E/G ratio of 3.13 and a beta of 1.02. The company has a debt-to-equity ratio of 6.68, a current ratio of 0.72 and a quick ratio of 0.72. Oracle Co. has a 1 year low of $99.26 and a 1 year high of $178.61.
Oracle (NYSE:ORCL – Get Free Report) last posted its quarterly earnings data on Monday, September 9th. The enterprise software provider reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.33 by $0.06. Oracle had a return on equity of 171.38% and a net margin of 20.40%. The business had revenue of $13.31 billion for the quarter, compared to analyst estimates of $13.23 billion. During the same quarter last year, the company earned $0.95 earnings per share. The business’s revenue for the quarter was up 6.9% compared to the same quarter last year. Sell-side analysts anticipate that Oracle Co. will post 5 EPS for the current fiscal year.
Oracle Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, October 24th. Investors of record on Thursday, October 10th were given a dividend of $0.40 per share. The ex-dividend date was Thursday, October 10th. This represents a $1.60 dividend on an annualized basis and a yield of 0.93%. Oracle’s dividend payout ratio (DPR) is currently 41.24%.
About Oracle
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
See Also
- Five stocks we like better than Oracle
- What is Forex and How Does it Work?
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
- What to Know About Investing in Penny Stocks
- Astera Labs’ Big Stock Jump: Can the Growth Be Sustained?
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.